Physician profile
Andrew E Dick
NPI 1376631184
$487.69
in general payments reported to CMS, 2019-2025
15 companies · $154 in 2025
The $154 reported for 2025 was more than what 75% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.68 · 2020: $29.67 · 2021: $129 · 2022: $36.51 · 2023: $31.33 · 2024: $87.88 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $60.82 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $55.00 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $53.56 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $48.72 | 2021-2022 | |
| Verona Pharma, INC. | $41.30 | 2025 | Ohtuvayre |
| Lundbeck LLC | $40.46 | 2024 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.33 | 2023 | Xifaxan |
| Inari Medical, INC. | $30.64 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Phathom Pharmaceuticals, INC. | $24.00 | 2025 | Voquezna |
| Abbott Laboratories | $19.68 | 2019 | |
| Axsome Therapeutics, INC. | $17.83 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.64 | 2020 | |
| Merck Sharp & Dohme LLC | $16.78 | 2024 | Bridion |
| Vertex Pharmaceuticals Incorporated | $15.96 | 2025 | |
| Mylan Specialty L.P. | $13.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Dick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.